You are here

Ozempic

Biohaven hopes to muscle in on Ozempic with a different type of weight loss drug

Biohaven hopes to muscle in on Ozempic with a different type of weight loss drug

BioPharma Dive

Flag link:

German regulator eyes Ozempic export ban amid shortages across Europe

German regulator eyes Ozempic export ban amid shortages across Europe

Reuters

Flag link:

Senator floats new models to manage costs of weight loss drugs like Ozempic

Senator floats new models to manage costs of weight loss drugs like Ozempic

Stat

Flag link:

Novo Nordisk shrugs off supply issues with record sales

Novo Nordisk shrugs off supply issues with record sales

Pharmaphorum

Flag link:

Demand for Ozempic and Wegovy Is Through the Roof. Here's Why it Can Go Even Higher.

Demand for Ozempic and Wegovy Is Through the Roof. Here's Why it Can Go Even Higher.

Motley Fool

Flag link:

Belgium plans temporary ban on use of Ozempic for weight loss

Belgium plans temporary ban on use of Ozempic for weight loss

Yahoo/Reuters

Flag link:

High-flying Novo Nordisk once again dials up its 2023 sales and profit expectations

High-flying Novo Nordisk once again dials up its 2023 sales and profit expectations

Fierce Pharma

Flag link:

Fresenius Medical: effect of drugs like Ozempic on patient numbers is neutral

Fresenius Medical: effect of drugs like Ozempic on patient numbers is neutral

Yahoo/Reuters

Fresenius Medical Care

Flag link:

Far More Employers Could Cover Weight Loss Drugs Like Wegovy Next Year—Here’s What That Means For Costs

Far More Employers Could Cover Weight Loss Drugs Like Wegovy Next Year—Here’s What That Means For Costs

Forbes

Flag link:

Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

CP Wire/Businesswire

Flag link:

Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Flag link:

2 Reasons Why Eli Lilly's Mounjaro Might Beat Novo Nordisk's Ozempic, and 2 Reasons Why It Might Not

2 Reasons Why Eli Lilly's Mounjaro Might Beat Novo Nordisk's Ozempic, and 2 Reasons Why It Might Not

Motley Fool

Flag link:

GLP-1 Agonists, Like Ozempic and Wegovy, Have Risk of Gut Issues: Study

GLP-1 Agonists, Like Ozempic and Wegovy, Have Risk of Gut Issues: Study

BioSpace

Flag link:

At Viatris' request, US agency will review another Novo Nordisk patent on semaglutide

At Viatris' request, US agency will review another Novo Nordisk patent on semaglutide

Fierce Pharma

Flag link:

US Patent Office won't review two Novo Nordisk patents for Wegovy, Ozempic

US Patent Office won't review two Novo Nordisk patents for Wegovy, Ozempic

Yahoo/Reuters

Flag link:

FDA Adds New Warning for Ileus to Ozempic Label

FDA Adds New Warning for Ileus to Ozempic Label

HCP Live

Flag link:

Obesity Drug Market Set to Hit $100 Billion by 2035, BMO Says

Obesity Drug Market Set to Hit $100 Billion by 2035, BMO Says

Yahoo/Bloomberg

Flag link:

Why a hidden message in Ozempic’s logo represents a big shift in drug branding

Why a hidden message in Ozempic’s logo represents a big shift in drug branding

Fast Company

Flag link:

After treatment with semaglutide, people with newly diagnosed type 1 diabetes needed little or no insulin

After treatment with semaglutide, people with newly diagnosed type 1 diabetes needed little or no insulin

Medical News Today

type 1 diabetes

Flag link:

Novo Nordisk Is Already Working on Ozempic 2.0

Novo Nordisk Is Already Working on Ozempic 2.0

Motley Fool

Flag link:

Pages